References
- Alloatti D, Giannini, G, Cabri W, Lustrati I, Marzi M, Ciacci A, Gallo G, Tinti MO, Marcellini M, Riccioni T, Guglielmi P, Pisano C. (2008). Synthesis and biological activity of fluorinated Combrestatin analogues. J. Med. Chem. 51: 2708-2721.
- Armitage JM, MacLead M, Cousins IT. (2009). Comparative assessment of the global fate and transport pathways of long-chain perfluorocarboxylic acids (PFCAs) and perfluorocarboxalates (PFCs) emitted from direct sources. Environ. Sci. Technol. 43: 5830-5836.
- Herzke D, Schlabach M, Mariussen E, Uggerud H, Heimstad E. (2007). A literature survey on selected chemical compounds. TA-2238/2007. http://www.sft.no/publikasjoner/2238/ta2238.pdf
- Broxterman HJ, Georgopapadakou NH. (2005). Anticancer Therapeutics: "Addictive" multi-targeted drugs, new drug combinations. Drug Resistance Updates 8: 183-197.
- Houde M, Martin JW, Letcher RJ, Solomon KR, Muir DCG. (2006). Biological monitoring of polyfluoroalkyl substances: A review. Environmental Science & Technology 40: 3463-3473.
- Kovarova J, Svobodova Z. (2008). Perfluorinated compounds: occurrence and risk - A review. Neurotoxicol. Letters 29: 599-608.
- Hariharan R, Bray M, Ganim R, Doenst T, Goodwin GW, Taegtmeyer H. (1995). Fundamental limitations of [18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake. Circulation 91: 2435-2444.
- Tichý M, Rucki M. (1996). An alternative method for determining acute toxicity of chemicals: cessation of movements in Tubifex tubifex worms. Pracov Lék 48: 225-230 [in czech].
- Tichý M, Rucki M, Hanzlíková I, Roth Z. (2007). The Tubifex tubifex assay for the determibation of acute toxicity. ATLA 35: 229-237.
- Tichý M, Rucki M, Hanzlíková I, Roth Z. (2008). Acute toxicity determination by calculation - Tubifex tubifex assay and quantitative structure - activity relationships Environ. Toxicol. Chem. 27: 2281-2286.
- Valigurova R. (2008). Thesis: Toxicity determination of salts of perfluorinated organic acids, Charles University in Prague.